NCT07618702

Brief Summary

Heat stress and dehydration are significant risks for diabetic pilgrims during the Hajj, often leading to severe complications. Standard Oral Rehydration Salts (ORS) are effective for rehydration but may cause hyperglycemia in diabetic patients due to their glucose content. This study aims to evaluate the efficacy and safety of a modified ORS formula ( Amr and khulood ORS) , specifically designed for diabetic individuals, in maintaining hydration without adversely affecting blood glucose levels. The study will involve a randomized controlled trial comparing the modified ORS (Amr and khulood ORS) with standard ORS among diabetic pilgrims experiencing heat stress. Key outcomes include hydration status, electrolyte balance, and glycemic control.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus

Timeline
10mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jun 2026Jun 2027

First Submitted

Initial submission to the registry

May 24, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 24, 2026

Last Update Submit

May 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in serum sodium levels from baseline to post-treatment

    Assessment of electrolyte balance by measuring the change in serum sodium levels (mmol/L) after the administration of ORS.

    Baseline and 24 hours post-treatment

Study Arms (2)

Modified ORS Group

EXPERIMENTAL

Participants in this group will receive the modified Oral Rehydration Salts ( Amr and khulood ORS) specifically designed for diabetic patients during the Hajj season to prevent dehydration and maintain electrolyte balance.

Other: Modified Oral Rehydration Salts (ORS)( Amr and khulood ORS)

Standard ORS Group

ACTIVE COMPARATOR

Participants in this group will receive the standard World Health Organization (WHO) Oral Rehydration Salts (ORS) formula.

Other: Standard Oral Rehydration Salts (ORS)

Interventions

Modified ORS formula ( Amr and khulood ORS) with adjusted electrolyte and carbohydrate content suitable for diabetic patients to prevent heat-related dehydration.

Modified ORS Group

Standard World Health Organization (WHO) ORS formula used as an active comparator.

Standard ORS Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diabetic pilgrims attending Hajj.
  • Age between 18 and 80 years.
  • Willingness to participate and provide informed consent.
  • Diagnosis of Type 1 or Type 2 Diabetes Mellitus.

You may not qualify if:

  • Patients with severe renal failure.
  • Patients with acute cardiovascular events.
  • Patients unable to take oral fluids.
  • Pregnancy or breastfeeding.
  • Participation in another clinical trial within the last 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ministry of health

Riyadh, Saudi Arabia

Location

MeSH Terms

Conditions

Diabetes MellitusHeat Stress Disorders

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesWounds and Injuries

Central Study Contacts

amr Central Research Office

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 1, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

June 1, 2026

Record last verified: 2026-05

Locations